Category:
Description:
Indications:
Contraindications:
-
Acute
porphyria
-
Porphyria
history
Precautions:
Adverse
Reactions (Side Effects):
-
CV:
cardiac disease, hypertension, hypotension, myxedema, peripheral
vascular disease
-
MISC:
respiratory insufficiency, anemia, adrenal insufficiency, shock,
uremia
|
Dosage:
Administered
intravenously, rectally
-
General
anesthesia induction and maintenance:
-
Adult:
-
IV
50-100mg initially, intermittent dose 20-40 seconds intervals,
or 3-5 mg/kg IV as single dose.
-
May
give additional doses up to 500mg max.
-
Once
anesthesia established, 25-50mg each time patient moves.
-
Alternatively,
a 0.2%-0.4% solution can be used as continuous drip; adjust
drip rate as necessary.
-
Child
1-12 years:
-
Infants:
-
Neonates:
-
Preanesthetic
induction:
-
Basal
narcosis:
-
Child:
-
Treatment
of increased intracranial pressure:
-
Treatment
of status epilepticus:
-
Adult:
-
IV
50-125mg as soon as possible after onset of seizures,
-
Seizures
caused by local anesthetics may require up to 250mg IV over 10
minutes
-
Narcoanalysis:
-
Adult:
IV slow injection 100 mg/min (4ml/min of a 2.5% solution) with
patient counting backwards from 100.
-
Stop
infusion after patient becomes confused, but before sleep.
-
All
patients to return to semidrowsy state where conversation is
coherent.
-
Alternatively,
a 0.2% solution in D5W may be given by rapid IV drip not greater
than 50 ml/min
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|